Infinity Pharmaceuticals retains regular Real Value of $1.9114 per share. The prevalent price of the corporation is $2.19. Based on Macroaxis valuation methodology, the corporation appears to be over valued. Macroaxis calculates value of Infinity Pharmaceuticals from evaluating the corporation fundamentals such as Shares Outstanding of 50.71M, Return On Asset of
(27.38)% and Return On Equity of (73.91)% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|
Infinity Pharmaceuticals Inc is rated fifth overall in price to book category among related companies. It is currently regarded as number one stock in beta category among related companies totaling about 1.43 of Beta per Price to Book.
Infinity Pharmaceuticals is abnormally risky asset. Calculation of real value of Infinity Pharmaceuticals is based on 1 month time horizon. Increasing Infinity Pharmaceuticals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.